Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

3.9K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
3.9K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

6.6K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
6.6K
Master Transcription Regulators02:23

Master Transcription Regulators

6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
GTPases and their Regulation02:14

GTPases and their Regulation

8.2K
Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒  small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins,...
8.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Label-Free Quantification of Bilirubin Using a Refractive Index-Insensitive Nanolaminate SERS Substrate.

Biosensors·2026
Same author

Corrigendum to "Molecular role of developmentally regulated GTP-binding protein 1 in coordinating osteoclast and osteoblast differentiation during bone remodeling" [Mol. Cells 49 (2026) 100342].

Molecules and cells·2026
Same author

Molecular role of developmentally regulated GTP-binding protein 1 in coordinating osteoclast and osteoblast differentiation during bone remodeling.

Molecules and cells·2026
Same author

Flexible Bayesian Inference for Identifying Significantly Correlated Multiple Pathway Sets.

Statistics in medicine·2026
Same author

CaMKIV negatively regulates osteoblast differentiation by modulating c-Fos and NFATc1 signaling: an in vitro and in vivo mechanistic study.

BMB reports·2026
Same author

MKRN1 Regulates RANKL-Induced Differentiation Via Akt and AMPK Pathways.

Journal of cellular physiology·2025

Related Experiment Video

Updated: May 29, 2025

Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes
11:52

Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes

Published on: January 27, 2023

2.9K

Rac1-dependent regulation of osteoclast and osteoblast differentiation by developmentally regulated GTP-binding 2.

Jung Ha Kim1, Semun Seong2,3, Kabsun Kim2

  • 1Department of Pharmacology, Chonnam National University Medical School, Gwangju, 61469, Republic of Korea. kjhpw@hanmail.net.

Cell Death Discovery
|February 5, 2025
PubMed
Summary

Developmentally regulated GTP-binding protein 2 (Drg2) impacts bone mass by controlling osteoclast and osteoblast activity via Rac1. Inhibiting Drg2 increases bone mass and protects against bone loss, suggesting Drg2 as a therapeutic target.

More Related Videos

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro
07:03

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro

Published on: June 16, 2022

5.9K
Differentiation and Characterization of Osteoclasts from Human Induced Pluripotent Stem Cells
10:52

Differentiation and Characterization of Osteoclasts from Human Induced Pluripotent Stem Cells

Published on: March 22, 2024

1.5K

Related Experiment Videos

Last Updated: May 29, 2025

Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes
11:52

Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes

Published on: January 27, 2023

2.9K
A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro
07:03

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro

Published on: June 16, 2022

5.9K
Differentiation and Characterization of Osteoclasts from Human Induced Pluripotent Stem Cells
10:52

Differentiation and Characterization of Osteoclasts from Human Induced Pluripotent Stem Cells

Published on: March 22, 2024

1.5K

Area of Science:

  • Bone Biology and Physiology
  • Cell Signaling
  • GTPase Biology

Background:

  • Small GTPases are critical regulators of bone homeostasis.
  • Osteoclasts and osteoblasts are key bone cells involved in bone remodeling.
  • The role of Drg2 in bone cell differentiation and function is not well understood.

Purpose of the Study:

  • To investigate the role of developmentally regulated GTP-binding protein 2 (Drg2) in regulating osteoclast and osteoblast differentiation and function.
  • To determine if Drg2 affects bone mass through Rac1 activation.
  • To evaluate Drg2 as a potential therapeutic target for bone loss.

Main Methods:

  • In vitro studies using siRNA to downregulate Drg2 in bone marrow-derived macrophages and calvarial-derived osteoprogenitor cells.
  • In vivo studies using Drg2-deficient mice and RANKL-induced bone loss models.
  • Assessment of osteoclast and osteoblast differentiation and function.
  • Analysis of Rac1 activation.

Main Results:

  • Drg2 downregulation inhibited osteoclast differentiation and function and Rac1 activation in vitro.
  • Drg2 downregulation enhanced osteoblast differentiation and function and suppressed Rac1 activation in vitro.
  • Drg2 deficiency in mice led to increased bone mass with reduced osteoclast numbers.
  • Drg2 downregulation inhibited RANKL-induced bone loss in vivo.
  • Rac1 inhibition restored differentiation suppressed by Drg2 downregulation.

Conclusions:

  • Drg2 regulates bone homeostasis by modulating osteoclast and osteoblast differentiation and function through Rac1 activation.
  • Drg2 plays a significant role in controlling bone mass, particularly through its effects on osteoclasts.
  • Drg2 represents a promising therapeutic target for treating bone loss-related diseases.